3P Biopharmaceuticals has expanded its analytical capacities and capabilities. The 3P Analytical Development Area is one of the company’s core competences and has been significantly upgraded with an investment of around $500,000.   In addition to the area expansion, 3P has also invested in state-of-the-art equipment and technology that increases its capabilities to support clients various needs for analytical methods development, process development and manufacturing of biopharmaceuticals.   3P ...